non-hirudineans only
僅非醫用水蛭
studying non-hirudineans
研究非醫用水蛭
identifying non-hirudineans
辨識非醫用水蛭
analyzing non-hirudineans
分析非醫用水蛭
excluding non-hirudineans
排除非醫用水蛭
presence of non-hirudineans
非醫用水蛭的存在
detecting non-hirudineans
檢測非醫用水蛭
surveying non-hirudineans
調查非醫用水蛭
classifying non-hirudineans
分類非醫用水蛭
researchers are investigating the efficacy of non-hirudineans in treating thrombosis.
研究人員正在調查非水蛭素類物質在治療血栓方面的效果。
the study focused on the coagulation properties of non-hirudineans compared to hirudin.
該研究專注於比較非水蛭素類物質與水蛭素的凝血特性。
non-hirudineans offer a potential alternative for patients with heparin-induced thrombocytopenia.
非水蛭素類物質為肝素誘導性血小板減少症患者提供了潛在的替代方案。
several synthetic non-hirudineans have been developed for clinical use.
已開發出多種合成的非水蛭素類物質用於臨床。
the binding affinity of non-hirudineans to thrombin varied significantly.
非水蛭素類物質與凝血酶的結合親和力存在顯著差異。
pharmacokinetic profiles of non-hirudineans are being carefully evaluated.
非水蛭素類物質的藥代動力學特性正在被仔細評估。
compared to traditional anticoagulants, non-hirudineans showed a different mechanism of action.
與傳統抗凝藥物相比，非水蛭素類物質表現出不同的作用機制。
the development of novel non-hirudineans remains an active area of research.
新型非水蛭素類物質的開發仍然是活躍的研究領域。
clinical trials are assessing the safety and efficacy of new non-hirudineans.
臨床試驗正在評估新型非水蛭素類物質的安全性和有效性。
the cost-effectiveness of non-hirudineans is a key consideration for healthcare providers.
非水蛭素類物質的成本效益是醫療提供者考慮的關鍵因素。
understanding the structure-activity relationship of non-hirudineans is crucial for drug design.
理解非水蛭素類物質的結構-活性關係對於藥物設計至關重要。
non-hirudineans only
僅非醫用水蛭
studying non-hirudineans
研究非醫用水蛭
identifying non-hirudineans
辨識非醫用水蛭
analyzing non-hirudineans
分析非醫用水蛭
excluding non-hirudineans
排除非醫用水蛭
presence of non-hirudineans
非醫用水蛭的存在
detecting non-hirudineans
檢測非醫用水蛭
surveying non-hirudineans
調查非醫用水蛭
classifying non-hirudineans
分類非醫用水蛭
researchers are investigating the efficacy of non-hirudineans in treating thrombosis.
研究人員正在調查非水蛭素類物質在治療血栓方面的效果。
the study focused on the coagulation properties of non-hirudineans compared to hirudin.
該研究專注於比較非水蛭素類物質與水蛭素的凝血特性。
non-hirudineans offer a potential alternative for patients with heparin-induced thrombocytopenia.
非水蛭素類物質為肝素誘導性血小板減少症患者提供了潛在的替代方案。
several synthetic non-hirudineans have been developed for clinical use.
已開發出多種合成的非水蛭素類物質用於臨床。
the binding affinity of non-hirudineans to thrombin varied significantly.
非水蛭素類物質與凝血酶的結合親和力存在顯著差異。
pharmacokinetic profiles of non-hirudineans are being carefully evaluated.
非水蛭素類物質的藥代動力學特性正在被仔細評估。
compared to traditional anticoagulants, non-hirudineans showed a different mechanism of action.
與傳統抗凝藥物相比，非水蛭素類物質表現出不同的作用機制。
the development of novel non-hirudineans remains an active area of research.
新型非水蛭素類物質的開發仍然是活躍的研究領域。
clinical trials are assessing the safety and efficacy of new non-hirudineans.
臨床試驗正在評估新型非水蛭素類物質的安全性和有效性。
the cost-effectiveness of non-hirudineans is a key consideration for healthcare providers.
非水蛭素類物質的成本效益是醫療提供者考慮的關鍵因素。
understanding the structure-activity relationship of non-hirudineans is crucial for drug design.
理解非水蛭素類物質的結構-活性關係對於藥物設計至關重要。
Explore frequently searched vocabulary
Want to learn vocabulary more efficiently? Download the DictoGo app and enjoy more vocabulary memorization and review features!
Download DictoGo Now